Lv3
296 积分 2024-03-29 加入
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial
2天前
已完结
Heart failure in children
6天前
已关闭
儿童心力衰竭诊断和治疗建议（2020年修订版）
6天前
已完结
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment
16天前
已完结
DNA测序结果的静脉/淋巴管畸形新基因分型
4个月前
已完结
The Prospective Natural History Study of Patients with Intractable Venous Malformation and Klippel–Trenaunay Syndrome to Guide Designing a Proof-of-Concept Clinical Trial for Novel Therapeutic Intervention
4个月前
已完结
Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance
4个月前
已完结
BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
4个月前
已完结
皖公网安备34019202002308
